147 related articles for article (PubMed ID: 38434653)
1. The antimicrobial effect of
Ananda N; Suniarti DF; Bachtiar EW
F1000Res; 2023; 12():1495. PubMed ID: 38434653
[TBL] [Abstract][Full Text] [Related]
2. Glycerol strengthens probiotic effect of Limosilactobacillus reuteri in oral biofilms: A synergistic synbiotic approach.
Van Holm W; Verspecht T; Carvalho R; Bernaerts K; Boon N; Zayed N; Teughels W
Mol Oral Microbiol; 2022 Dec; 37(6):266-275. PubMed ID: 36075698
[TBL] [Abstract][Full Text] [Related]
3. Microbiota and Probiotics: The Role of Limosilactobacillus Reuteri in Diverticulitis.
Piccioni A; Franza L; Vaccaro V; Saviano A; Zanza C; Candelli M; Covino M; Franceschi F; Ojetti V
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441008
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Probiotics Targeting Clostridium difficile through Precursor-Directed Antimicrobial Biosynthesis.
Spinler JK; Auchtung J; Brown A; Boonma P; Oezguen N; Ross CL; Luna RA; Runge J; Versalovic J; Peniche A; Dann SM; Britton RA; Haag A; Savidge TC
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760934
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
[TBL] [Abstract][Full Text] [Related]
6. Clinical and microbiological evaluation of the effect of Lactobacillus reuteri in the treatment of mucositis and peri-implantitis: A triple-blind randomized clinical trial.
Galofré M; Palao D; Vicario M; Nart J; Violant D
J Periodontal Res; 2018 Jun; 53(3):378-390. PubMed ID: 29352461
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of Lactobacillus reuteri on periodontopathic and cariogenic bacteria.
Kang MS; Oh JS; Lee HC; Lim HS; Lee SW; Yang KH; Choi NK; Kim SM
J Microbiol; 2011 Apr; 49(2):193-9. PubMed ID: 21538238
[TBL] [Abstract][Full Text] [Related]
8. Glycerol and reuterin-producing Limosilactobacillus reuteri enhance butyrate production and inhibit Enterobacteriaceae in broiler chicken cecal microbiota PolyFermS model.
Asare PT; Greppi A; Geirnaert A; Pennacchia A; Babst A; Lacroix C
BMC Microbiol; 2023 Dec; 23(1):384. PubMed ID: 38053034
[TBL] [Abstract][Full Text] [Related]
9. In vitro assessment of the effect of probiotic lactobacillus reuteri on peri-implantitis microflora.
Mulla M; Mulla M; Hegde S; Koshy AV
BMC Oral Health; 2021 Aug; 21(1):408. PubMed ID: 34412595
[TBL] [Abstract][Full Text] [Related]
10. Lactobacillus reuteri derived from horse alleviates Escherichia coli-induced diarrhea by modulating gut microbiota.
Wang D; Zeng J; Wujin C; Ullah Q; Su Z
Microb Pathog; 2024 Mar; 188():106541. PubMed ID: 38224920
[TBL] [Abstract][Full Text] [Related]
11. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial.
Flichy-Fernández AJ; Ata-Ali J; Alegre-Domingo T; Candel-Martí E; Ata-Ali F; Palacio JR; Peñarrocha-Diago M
J Periodontal Res; 2015 Dec; 50(6):775-85. PubMed ID: 25712760
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Limosilactobacillus reuteri LR-99 Supplementation on Body Mass Index, Social Communication, Fine Motor Function, and Gut Microbiome Composition in Individuals with Prader-Willi Syndrome: a Randomized Double-Blinded Placebo-Controlled Trial.
Kong XJ; Liu K; Zhuang P; Tian R; Liu S; Clairmont C; Lin X; Sherman H; Zhu J; Wang Y; Fong M; Li A; Wang BK; Wang J; Yu Z; Shen C; Cui X; Cao H; Du T; Wan G; Cao X
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1508-1520. PubMed ID: 34115318
[TBL] [Abstract][Full Text] [Related]
13. Probiotic Monotherapy with
Salinas-Azuceno C; Martínez-Hernández M; Maldonado-Noriega JI; Rodríguez-Hernández AP; Ximenez-Fyvie LA
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805491
[TBL] [Abstract][Full Text] [Related]
14. Limosilactobacillus reuteri SLZX19-12 Protects the Colon from Infection by Enhancing Stability of the Gut Microbiota and Barrier Integrity and Reducing Inflammation.
Wu J; Lin Z; Wang X; Zhao Y; Zhao J; Liu H; Johnston LJ; Lu L; Ma X
Microbiol Spectr; 2022 Jun; 10(3):e0212421. PubMed ID: 35658572
[TBL] [Abstract][Full Text] [Related]
15. Culturing the Chicken Intestinal Microbiota and Potential Application as Probiotics Development.
Ma K; Chen W; Lin XQ; Liu ZZ; Wang T; Zhang JB; Zhang JG; Zhou CK; Gao Y; Du CT; Yang YJ
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769368
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory activity spectrum of reuterin produced by Lactobacillus reuteri against intestinal bacteria.
Cleusix V; Lacroix C; Vollenweider S; Duboux M; Le Blay G
BMC Microbiol; 2007 Nov; 7():101. PubMed ID: 17997816
[TBL] [Abstract][Full Text] [Related]
17.
Dargenio C; Dargenio VN; Bizzoco F; Indrio F; Francavilla R; Cristofori F
Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34357014
[No Abstract] [Full Text] [Related]
18. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
19. Investigation of probiotic bacteria as dental caries and periodontal disease biotherapeutics.
Saha S; Tomaro-Duchesneau C; Rodes L; Malhotra M; Tabrizian M; Prakash S
Benef Microbes; 2014 Dec; 5(4):447-60. PubMed ID: 25006013
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice.
Lee J; Yang W; Hostetler A; Schultz N; Suckow MA; Stewart KL; Kim DD; Kim HS
BMC Microbiol; 2016 Apr; 16():69. PubMed ID: 27095067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
